University of Rhode Island
Use of efaproxiral in brain metastases from breast cancer improved survival
Published in Pharma Investments, Ventures and Law Weekly, February 12th, 2006
According to an article published in the journal Annals of Pharmacotherapy, scientists in the United States conducted a study "to review the mechanism of action and clinical data of efaproxiral use in brain metastases of breast cancer. Articles were identified through MEDLINE (1966-June 2005) and EMBASE (1980-May 2005) searches using the keywords efaproxiral and RSR13."
"Published abstracts over the previous 10 years from various scientific meetings, including American Society of Clinical Oncology and San Antonio Breast Cancer...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- Acadia Pharmaceuticals, Inc.
Pharmaceutical company reports additional $10M equity investment by Sepracor - Adlyfe, Inc.
Protein detection technology developer secures $3.3M in series A round - Advanced BioPhotonics Inc.
Medical imaging company restructures and reduces board of directors - Advanced BioPhotonics, Inc.
Imaging company closes on second financing milestone - Akorn, Inc.
Ophthalmic drug developer retires series A preferred stock - Aksys, Ltd.
Dialysis systems developer reports $20M stock purchase agreement - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
